|

Nitrous oxide Clinical Trials

3 actively recruiting trials across 3 locations

No change since May 2026

Also known as: Self-adjusted nitrous oxide, laughing gas

Pipeline

Phase 1: 1Phase 2: 1Phase 4: 1

Top Sponsors

  • Washington University School of Medicine1
  • Stanford University1
  • Beth Israel Deaconess Medical Center1

Indications

  • Anxiety2
  • Procedural Anxiety1
  • Pain Catastrophizing1
  • Depressive Disorder, Treatment-Resistant1
  • Obsessive-compulsive Disorder1

Stanford, California1 trial

Efficacy of Nitrous Oxide in OCD: Pilot Study

Stanford University

Phase 2

Boston, Massachusetts1 trial

Self-Adjusted Nitrous Oxide: A Feasibility Study in the Setting of Vasectomy

Beth Israel Deaconess Medical Center

Phase 4

St Louis, Missouri1 trial

NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits

Washington University School of Medicine

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.